Primary Care for HIV-Infected Patients in Resource-Limited Settings

  • Authors: Charles van der Horst, MD; F. Parker Hudson, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 9/4/18 (What's New)

Summary

  • Patients unable to tolerate adverse effects require ART modification (Table 7)
  • Stavudine is associated with toxicities such as lipodystrophy, metabolic syndrome, lactic acidosis, pancreatitis, and peripheral neuropathy, and should no longer be used in first-line ART regimens[WHO ART]

Action required

Keywords: Adherence, Initial Antiretroviral Therapy, Resource-Limited Settings, Special Populations, Switch Strategies, Treatment Complications

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.